Human genetics: international projects and personalized medicine

Area of Science:

• Human Genetics
• Pharmacogenomics
• Genomic Technologies

Background:

• Technological advancements in massive sequencing are transforming human genetics.
• Large-scale genetic variation data is available from projects like 1000 Genomes and GTEx.
• Epigenetic variations significantly influence gene expression and drug metabolism.

Purpose of the Study:

• To review progress in human genetics driven by new technologies.
• To discuss the application of genetic and epigenetic data in drug response prediction.
• To highlight the role of international genomic projects in advancing the field.

Main Methods:

• Review of recent technological advances in massive sequencing.
• Analysis of data from major human genetics projects (1000 Genomes, GTEx, TCGA, ICGC).
• Discussion of epigenetic variation and its impact on gene expression and drug metabolism.

Main Results:

• Massive sequencing technologies have accelerated human genetics research.
• Germline genetic variations and phenome-genome data are crucial for understanding drug response.
• International collaborative projects provide comprehensive genomic and cancer data.

Conclusions:

• New technologies and large-scale data are revolutionizing human genetics and pharmacogenomics.
• Understanding genetic and epigenetic factors is key to personalized drug response prediction.
• Continued international collaboration is essential for advancing genomic medicine.